Targeting T cells in myasthenia gravis
β Scribed by Daniel B. Drachman
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 90 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Discussion This study shows that replacing one anticonvulsant drug with another is beneficial for nearly 1 in 3 patients (18 of 59; 31%) with generalized tonic-clonic or partial seizures in whom a previous single-drug therapy up to individual tolerance has failed. In addition, side effects disa
## Abstract The constrictionβdilation cycles of pupils exposed to a stationary, discrete slitβlamp beam were significantly prolonged in 25 myasthenic patients (1,060.4 Β± 45.8 msec) undergoing therapy with steroids, anticholinesterases, or both, compared to normal controls (801.9 Β± 8.6 msec) or subj
Four patients with myasthenia gravis presented with severe, largely isolated, bulbar and respiratory muscles weakness. Tensilon tests were positive and antiacetylcholine receptor (anti-AChR) antibody titers were negative in all patients. Only 1 patient had a greater than 10% decremental response dur
## Abstract Lymphocytes from the thymus glands of myasthenic patients and controls were characterized in terms of their percentages of Bβ and Tβcells and their ability to stimulate the proliferation of autologous peripheral blood lymphocytes. Percentages of Bβ and Tβcells were the same in the thymu